Belluscura Plc
Belluscura plc develops and commercialize oxygen related medical device products in the United States. The company offers X-PLOR and DISCOV-R, a modular portable oxygen concentrator; and related accessories. Belluscura plc was incorporated in 2015 and is based in London, the United Kingdom.
Belluscura Plc (BELL) - Total Assets
Latest total assets as of June 2024: GBX21.49 Million GBX
Based on the latest financial reports, Belluscura Plc (BELL) holds total assets worth GBX21.49 Million GBX as of June 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Belluscura Plc - Total Assets Trend (2016–2023)
This chart illustrates how Belluscura Plc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Belluscura Plc - Asset Composition Analysis
Current Asset Composition (December 2023)
Belluscura Plc's total assets of GBX21.49 Million consist of 41.1% current assets and 58.9% non-current assets.
| Asset Category | Amount (GBX) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 4.5% |
| Accounts Receivable | GBX99.80K | 0.5% |
| Inventory | GBX3.32 Million | 16.0% |
| Property, Plant & Equipment | GBX0.00 | 0.0% |
| Intangible Assets | GBX9.99 Million | 48.0% |
| Goodwill | GBX0.00 | 0.0% |
Asset Composition Trend (2016–2023)
This chart illustrates how Belluscura Plc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Belluscura Plc's current assets represent 41.1% of total assets in 2023, a decrease from 86.0% in 2016.
- Cash Position: Cash and equivalents constituted 4.5% of total assets in 2023, down from 79.3% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 47.0% of total assets, an increase from 11.0% in 2016.
- Asset Diversification: The largest asset category is intangible assets at 48.0% of total assets.
Belluscura Plc Competitors by Total Assets
Key competitors of Belluscura Plc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Belluscura Plc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Belluscura Plc generates 0.04x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Belluscura Plc is currently not profitable relative to its asset base.
Belluscura Plc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.25 | 8.89 | 2.83 |
| Quick Ratio | 2.09 | 4.17 | 2.63 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | GBX6.52 Million | GBX 14.72 Million | GBX 583.23K |
Belluscura Plc - Advanced Valuation Insights
This section examines the relationship between Belluscura Plc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.21 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -11.8% |
| Total Assets | GBX20.82 Million |
| Market Capitalization | $366.21 USD |
Valuation Analysis
Below Book Valuation: The market values Belluscura Plc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Belluscura Plc's assets decreased by 11.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Belluscura Plc (2016–2023)
The table below shows the annual total assets of Belluscura Plc from 2016 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | GBX20.82 Million | -11.76% |
| 2022-12-31 | GBX23.60 Million | -9.25% |
| 2021-12-31 | GBX26.00 Million | -15.36% |
| 2020-12-31 | GBX30.73 Million | +578.32% |
| 2019-12-31 | GBX4.53 Million | +77.59% |
| 2018-12-31 | GBX2.55 Million | +34.86% |
| 2017-12-31 | GBX1.89 Million | +17.26% |
| 2016-11-30 | GBX1.61 Million | -- |